Abstract
Myasthenia gravis (MG) is prototypical neurological autoimmune disorder,characterized by limb and occulo-bulbular fragility. Our case study will facilitate the practitionersas well as the scientific community to consider other therapy plans with patients presented withacute respiratory failure due to the use of rituximab.A 25-year-old man presented with acuterespiratory failure This case reporte sheds light on the importance of differential diagnoses ofrefractory myasthenia gravis for inexplicable acute respiratory failure upon rituximab treatment.The case study demonstrates the problems associated with use of rituximab in refractorymyasthenia gravis. It can cause acute respiratory failure among the patients with relapsespecially. Our case study will facilitate the practitioners as well as the scientific community toconsider other therapy plans with patients presented with acute respiratory failure due to theuse of rituximab.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
